← Leaderboards
Gonul Schara
California State University-Stanislaus
$408,360
Attributed
$408,360
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $107.3K · FY2020–23$200K$150K$100K$50K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$408,360 · 1
By mechanism
SC3$408,360 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Drug Biological Activity”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$235,521,096
- John Damon Chodera · Sloan-Kettering Inst Can Research$54,583,179
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
Research focus
Drug Biological ActivityAnilineAreaActive SitesBioremediationsBupropionCareerCareer DevelopmentAgarCatalystCellsChemical SynthesisChemistryClinical ResearchCodon NucleotidesCofactorColorComputerized ToolsCostCatalysisCytochrome P450DisadvantagedDockingDrug Development
Grant awards (4)
Characterizing and engineering toluene o-xylene monooxygenase for the synthesis of common drug metabolites$107,250
SC3 · FY2023 · GM · contact PI
Characterizing and engineering toluene o-xylene monooxygenase for the synthesis of common drug metabolites$102,090
SC3 · FY2022 · GM · contact PI
Characterizing and engineering toluene o-xylene monooxygenase for the synthesis of common drug metabolites$100,370
SC3 · FY2021 · GM · contact PI
Characterizing and engineering toluene o-xylene monooxygenase for the synthesis of common drug metabolites$98,650
SC3 · FY2020 · GM · contact PI